Contract Manufacturing News: Breaking Contract Manufacturing News, Comments and Articles. - Page: 2

13:06 EDT 31st October 2014 | BioPortfolio

Contract Manufacturing News - Page: 2Twitter RSS

Read the latest Contract Manufacturing News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Contract Manufacturing.

Search or Follow Our Contract Manufacturing - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Contract Manufacturing - Page: 2 News.
You can also follow our Contract Manufacturing - Page: 2 news stories on Twitter: @cro_bio

Showing "contract manufacturing" News Articles 26 to 50 of 7,700+

Thursday 30th October 2014

Novo Nordisk to hire 90 at newly acquired plant in New Hampshire

Novo Nordisk on Wednesday announced plans to hire up to 90 people at its newly-acquired manufacturing facility in West Lebanon, New Hampshire. 

CDMO Paragon Bioservices raises $13m in financing

Contract research and manufacturing organization Paragon Bioservices has raised $13m in a Series A Preferred Stock financing, led by NewSpring Capital and Camden Partners, to continue to grow the company.

Strata Decision Technology is Named Winner of 13th Annual Chicago Innovation Award

CHICAGO, Oct. 30, 2014 /PRNewswire/ -- Strata Decision Technology (Strata Decision) has been named one of the winners of the 13th annual Chicago Innovation Awards. The Company's cloud-based financial analytics and performance platform, StrataJazz®, is leveraged for financial planning, decision support, and continuous cost improvement by over 1,000 hospitals in the U.S.   There were...

Medidata Selected by ASLAN Pharmaceuticals as Enterprise-Wide Technology Platform for Enhancing Clinical Development

Clinical Phase Company Adopts Medidata Platform to Bring Operational Efficiencies and Greater Speed to Its Clinical Trials Across Asia Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has signed an enterprise agreement with

Axalta Coating Systems Employees Celebrate Breast Cancer Awareness Month

Axalta’s North American facilities show their pink Employees at Axalta Coating Systems, a leading manufacturer of liquid and powder coatings, celebrated Breast Cancer Awareness month by wearing pink. Hundreds of North American team members participated in “Get Your Pink On” day to show their support for co-workers, family members, friends and any...

Kindred Names Benjamin A. Breier Chief Executive Officer-elect

Chief Executive Officer Paul J. Diaz to Become Executive Vice Chairman of the Kindred Board of Directors Kindred Healthcare, Inc. (the “Company” or “Kindred”) (NYSE:KND) today announced that Benjamin A. Breier will become Chief Executive Officer on March 31, 2015, succeeding Paul J. Diaz who will become Executive Vice Chairman of the Kindred Bo...

Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

LONDON, Oct. 30, 2014 /PRNewswire/ -- Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Microfluidic devices have several applications in the field of medicine, cell biology research and protein crystallization. Thus, microfluidic technology is an important tool to reduce side effects and improve the efficacy of treatments. It has ma...

Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar

Two separate delegations of dairy quality executives from Latin America were hosted by Charm Sciences at its Andover, Massachusetts facility in September and October in an exchange of ideas, experiences and best practices. Lawrence, MA (PRWEB) October 30, 2014 Two separate delegations of dairy quality executives from Latin America were hosted by Charm Sciences at its Andover, Massachusetts facili...

PerkinElmer Announces Financial Results for the Third Quarter of 2014

Revenue growth of 4%; organic and adjusted revenue growth of 4% GAAP earnings per share from continuing operations of $0.38; adjusted earnings per share increased 14% to $0.57 Expanded adjusted operating profit margin by 110 basis points Strong cash flow from continuing operations of $63 million ...

Fluidigm Reports Q3 2014 Results

Strong Q3 2014 organic revenue growth of 35% year-over-year Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the third quarter ended September 30, 2014. Total revenue for the third quarter of 2014 was $29.6 million, an increase of 62% from $18.3 million in the third quarter of 2013. Organic revenue (excluding revenu...

Texas Translation Company Passes an ISO Re-certification Audit

Teneo Linguistics Company, LLC, is an award winning, ISO certified provider of foreign language translation services based in Fort Worth, TX. The ISO 9001:2008 re-certification audit took place at the company's headquarters on October 28th and 29th, 2014. Fort Worth, Texas (PRWEB) October 30, 2014 Teneo Linguistics Company, LLC, has passed its ISO 9001:2008 recertification audit. The company,...

Amgen sues Sandoz over filgrastim biosimilar BLA

In the first lawsuit filed by an originator company over a biosimilars application, Amgen Inc. (NASDAQ:AMGN) alleged that the Sandoz unit of Novartis AG (NYSE:NVS; SIX:NOVN) has unlawfully refused to follow the patent resolution protocol laid out by ...

Sanitary Belt Conveyor

Sanitary Belt Conveyor is designed for bulk tablets, capsules, softgels, and powders as well as ingredients on regulated and OTC pharmaceutical and nutritional supplement manufacturing and packaging lines.Read more about Sanitary Belt Conveyor Comme...

Cirrus Pharmaceuticals, a Kemwell company, to invest in cGMP Manufacturing Suite in US

Cirrus Pharmaceuticals, a Kemwell company, which is a 100% services oriented company providing pharmaceutical contract development and manufacturing services, announced that it will be investing in a flexible cGMP suite in its facility in RTP, North Carolina. Ninad Deshpanday, President of R&D at Kemwell said, “With this investment, we are b...

Game Changing Migraine Medication To Be Available November 2014

LOS ANGELES, Oct. 30, 2014 /PRNewswire/ -- Migranade, Inc. announced today the new migraine medication, MIGRANADE Migraine Relief will be available to the 36 million U.S. migraine sufferers November, 2014. The medicine is developed from a platform technology that targets the actual cause of migraines and not just the symptoms. While all migraine medications attack pain and not the source Migranade...

Photos of the Day: 3D Printed Injection Molding

Stratasys’ Objet500 Connex 3D Printer takes its place in the traditional manufacturing floor at Worrell.Read more about Photos of the Day: 3D Printed Injection MoldingComments

Bristol-Myers, Lonza Expand Manufacturing Agreement

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Co. (BMY) and Lonza on Thursday announced a multi-year expansion of their existing biologics manufacturing agreement. The contract expansion will inc...

Unilife Corporation To Announce Financial Results For Fiscal Year 2015 First Quarter On Monday, November 10, 2014

YORK, Pa., Oct. 30, 2014 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS;  ASX: UNS) announced today that it intends to release its financial results for the fiscal 2015 first quarter ended September 30, 2014 after market trading ends on Monday, November 10, 2014. Management has scheduled a conference call for 4:30 p.m. U.S. EST on Monday, November 10, 2014 (...

ICT News Desk: Studying Staph

Staph aureus and MRSA continue to be among the most common pathogens that overwhelm the immune system, causing serious skin, soft tissue and life-threatening bloodborne infections. Researchers at NYU Langone Medical Center will lead a consortium of five institutions on a $6.5 million contract from the NIH directed at discovery of the fundamental

Avitus Orthopaedics Raises $1 Million to Assist with Launch of Avitus Harvester

Investment supports product launch and product portfolio expansion Farmington, Conn. (PRWEB) October 30, 2014 Avitus™ Orthopaedics Inc. a developer of orthopaedic tools that aim to improve clinical outcomes while decreasing healthcare costs for patients, surgeons, and hospitals, today announced it has recently raised more than $1 million in capital to continue commercialization and company grow...

BTS Research (BTS) licenses Xybion’s Pristima Suite™

Xybion provides a multi-year SaaS Subscription to the California-based GLP Contract Research Organization, BTS Research for management of preclinical studies Morris Planes, NJ (PRWEB) October 30, 2014 Xybion Corporation, the leading provider of software, services and consulting for global corporations operating in highly regulated industries announced that BTS Research (formerly BioTox Sciences a...

New Jersey Law Firm Handling Ebola and Employment Related Issues in Wake of Outbreak

Wilentz, Goldman & Spitzer shareholder, Dominick J. Bratti, recommends companies take a proactive approach to address legal issues that may arise from Ebola-related issues. Woodbridge, NJ (PRWEB) October 30, 2014 Wilentz, Goldman & Spitzer, a New Jersey based law firm, is handling Ebola-related questions and concerns companies and businesses may have related to employment issues. “Busin...

Dyadic International To Announce Third Quarter 2014 Financial Results And Host Conference Call On Thursday, November 13, 2014

JUPITER, Fla., Oct. 30, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for the t...

Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement

Bristol-Myers Squibb Company (NYSE:BMY) and Lonza today announced a multi-year expansion of their existing biologics manufacturing agreement. The contract expansion will include the production of commercial quantities of a second Bristol-Myers Squibb biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, New Hampshire. Financ

Technical Sheet: Charles River Accugenix® MALDI-TOF enhancements for bacterial identifications enable improved root cause analysis

Library coverage is often a topic of discussion for microbiologists wanting to know what the impact or relevancy of the Charles River Accugenix® library databases is on the identification of environmental, EM or industrial microorganisms. As a contr...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks